These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36996994)

  • 1. Lithium engages autophagy for neuroprotection and neuroplasticity: Translational evidence for therapy.
    Puglisi-Allegra S; Lazzeri G; Busceti CL; Giorgi FS; Biagioni F; Fornai F
    Neurosci Biobehav Rev; 2023 May; 148():105148. PubMed ID: 36996994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translational evidence for lithium-induced brain plasticity and neuroprotection in the treatment of neuropsychiatric disorders.
    Puglisi-Allegra S; Ruggieri S; Fornai F
    Transl Psychiatry; 2021 Jul; 11(1):366. PubMed ID: 34226487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A systematic analysis of neurobiological roles of lithium].
    Gogoleva IV; Gromova OA; Torshin IY; Grishina TR; Pronin AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11):17-23. PubMed ID: 36440772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural progenitor cells derived from lithium responsive and non-responsive bipolar disorder patients exhibit distinct sensitivity to cell death following methamphetamine.
    Mishra HK; Mandyam AD; Trenet W; Wei H; Nievergelt CM; Maihofer AX; Shilling PD; Alda M; Gershon E; McInnis MG; ; Kelsoe JR; McCarthy MJ
    Neuropharmacology; 2023 Mar; 226():109410. PubMed ID: 36608815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroprotective actions of lithium].
    Hashimoto R; Fujimaki K; Jeong MR; Senatorov VV; Christ L; Leeds P; Chuang DM; Takeda M
    Seishin Shinkeigaku Zasshi; 2003; 105(1):81-6. PubMed ID: 12701214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is There Justification to Treat Neurodegenerative Disorders by Repurposing Drugs? The Case of Alzheimer's Disease, Lithium, and Autophagy.
    Damri O; Shemesh N; Agam G
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium as a Neuroprotective Agent for Bipolar Disorder: An Overview.
    Ochoa ELM
    Cell Mol Neurobiol; 2022 Jan; 42(1):85-97. PubMed ID: 34357564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?
    Chuang DM
    Crit Rev Neurobiol; 2004; 16(1-2):83-90. PubMed ID: 15581403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy as a gateway for the effects of methamphetamine: From neurotransmitter release and synaptic plasticity to psychiatric and neurodegenerative disorders.
    Limanaqi F; Busceti CL; Celli R; Biagioni F; Fornai F
    Prog Neurobiol; 2021 Sep; 204():102112. PubMed ID: 34171442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders.
    Forlenza OV; De-Paula VJ; Diniz BS
    ACS Chem Neurosci; 2014 Jun; 5(6):443-50. PubMed ID: 24766396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective action of lithium in disorders of the central nervous system.
    Chiu CT; Chuang DM
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):461-76. PubMed ID: 21743136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy status as a gateway for stress-induced catecholamine interplay in neurodegeneration.
    Fornai F; Puglisi-Allegra S
    Neurosci Biobehav Rev; 2021 Apr; 123():238-256. PubMed ID: 33497785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms.
    Won E; Kim YK
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29232923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttranslational modifications & lithium's therapeutic effect-Potential biomarkers for clinical responses in psychiatric & neurodegenerative disorders.
    Khayachi A; Schorova L; Alda M; Rouleau GA; Milnerwood AJ
    Neurosci Biobehav Rev; 2021 Aug; 127():424-445. PubMed ID: 33971223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential application of lithium in Parkinson's and other neurodegenerative diseases.
    Lazzara CA; Kim YH
    Front Neurosci; 2015; 9():403. PubMed ID: 26578864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington's disease.
    Doria JG; Silva FR; de Souza JM; Vieira LB; Carvalho TG; Reis HJ; Pereira GS; Dobransky T; Ribeiro FM
    Br J Pharmacol; 2013 Jun; 169(4):909-21. PubMed ID: 23489026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders.
    Bauer M; Alda M; Priller J; Young LT;
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S250-4. PubMed ID: 14677087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium's role in neural plasticity and its implications for mood disorders.
    Gray JD; McEwen BS
    Acta Psychiatr Scand; 2013 Nov; 128(5):347-61. PubMed ID: 23617566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium neuroprotection: molecular mechanisms and clinical implications.
    Rowe MK; Chuang DM
    Expert Rev Mol Med; 2004 Oct; 6(21):1-18. PubMed ID: 15488156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator.
    Machado-Vieira R
    J Affect Disord; 2018 Jun; 233():92-99. PubMed ID: 29310970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.